Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Women preparing for IVF often face a difficult choice: continue weight loss medications that improve metabolic health, or pause them during fertility treatment. Current reproductive medicine guidelines suggest stopping GLP-1 agonists like semaglutide at least 2–3 months before ovarian stimulation begins, though individual timelines vary based on clinical circumstances and your fertility specialist's recommendations.
Why Reproductive Doctors Recommend Pausing GLP-1 Therapy Before IVF
GLP-1 medications alter gastric emptying and appetite regulation through the nervous system. While these changes support weight loss, they also affect nutrient absorption and metabolic stability—factors fertility clinics monitor closely during egg retrieval and implantation. Most reproductive endocrinologists request a 60–90 day washout period before starting ovarian stimulation to allow your digestive and endocrine systems to return to baseline.
The concern is not toxicity but rather stability. IVF success depends on precise hormone levels, egg quality, and uterine receptivity. Introducing or maintaining any medication that influences metabolic processes during this sensitive window introduces variables that may complicate egg development, embryo transfer, or early pregnancy support. Pausing semaglutide allows your healthcare team to isolate and optimize fertility-specific factors.
Stopping GLP-1 therapy temporarily does not erase weight loss already achieved. Many patients maintain or continue modest weight reduction in the months after stopping the medication, especially if they've developed new eating patterns and exercise habits during active treatment.
The Timeline: When to Stop Semaglutide if You're Pursuing IVF
If you're currently taking semaglutide and planning IVF, coordinate with both your primary care doctor and reproductive endocrinologist to establish a unified timeline. Most fertility centers recommend discontinuing semaglutide injection at least 8–12 weeks before your egg retrieval date, depending on your individual health profile and the dose you've been taking.
Work backward from your planned retrieval date. If you schedule IVF for September, pause semaglutide in June or earlier. This buffer allows enough time for your appetite, metabolism, and hormone patterns to stabilize before your fertility clinic begins baseline testing and hormone monitoring. Your reproductive endocrinologist may want to see 2–3 normal menstrual cycles off GLP-1 therapy to ensure cycle stability.
Some patients choose to resume semaglutide after pregnancy confirmation or after the first trimester, once organogenesis is complete. Others prefer to wait until after breastfeeding. These decisions should involve your obstetrician and fertility specialist, as pregnancy itself changes medication safety profiles.
Weight Loss Before IVF: Building a Sustainable Plan
One of the strongest predictors of IVF success is body mass index (BMI) in the normal to overweight range. Studies show that women with BMI above 30 experience lower fertilization rates, fewer viable eggs, and reduced implantation success. If you're considering IVF and currently taking semaglutide, you have the opportunity to reach your weight loss goal before stopping the medication—then maintain that progress during your fertility journey.
Begin your semaglutide therapy 6–9 months before your planned IVF cycle if possible. This window gives you time to titrate your dose safely, achieve meaningful weight loss, and build sustainable habits around nutrition and movement. By the time you pause the medication in preparation for fertility treatment, your new baseline weight becomes your launching point for IVF.
PlexusDx Semaglutide Injection starts at $149/month across all commitment tiers, with no flat per-compound pricing increases—meaning your investment in pre-fertility weight loss remains affordable regardless of your therapeutic dose. Combining semaglutide with structured nutrition support and exercise creates the metabolic foundation that benefits both weight management and egg quality.
After IVF: Restarting Weight Loss Therapy Safely
Once you receive a positive pregnancy test and your obstetrician confirms clinical viability, restarting semaglutide is typically not advised during pregnancy or breastfeeding due to limited safety data. However, many patients successfully resume GLP-1 therapy in the postpartum period, particularly after breastfeeding concludes if applicable. Your ob-gyn will guide timing based on your individual situation.
The weight regain that sometimes occurs during fertility treatment and pregnancy can feel discouraging, but it does not undo the metabolic benefits you achieved during active semaglutide therapy. When you're ready to restart—whether that's weeks or months postpartum—you're beginning from a position of prior success, not from scratch. Many patients find that restarting semaglutide after a planned break feels less disruptive than continuous therapy would.
PlexusDx remains available across all 50 states without insurance or membership requirements, so restarting compounded semaglutide injection fits easily into your postpartum health routine. Your fertility journey and weight management are separate chapters of your health story, and both deserve individualized, coordinated care.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take semaglutide while doing IVF?
No—reproductive endocrinologists recommend pausing semaglutide at least 2–3 months before ovarian stimulation begins. GLP-1 medications affect nutrient absorption and metabolic stability, which fertility clinics need to control precisely during egg retrieval and embryo development. Work with both your fertility specialist and primary doctor to set a safe discontinuation timeline.
Will stopping semaglutide cause me to regain weight before IVF?
Not necessarily. If you've been on semaglutide for 6+ months, you've likely developed new eating habits and exercise routines that persist after stopping the medication. Many patients maintain their weight loss during a 2–3 month pause, especially with continued attention to nutrition and activity. Your fertility clinic can also provide dietary guidance during this transition.
Can I start semaglutide after IVF pregnancy is confirmed?
No. GLP-1 agonists are not recommended during pregnancy or breastfeeding because long-term fetal safety data are limited. Most patients resume semaglutide after breastfeeding ends or in the postpartum period with their obstetrician's clearance. PlexusDx semaglutide is available whenever you're ready to restart at just $149/month.
Does being overweight actually affect IVF success rates?
Yes. Research shows that elevated BMI correlates with lower egg quality, reduced fertilization rates, and decreased implantation success. Weight loss of 5–10% can improve ovulation regularity and fertility outcomes. This is why many reproductive endocrinologists recommend achieving a healthier weight before IVF—and why semaglutide therapy in the months before fertility treatment offers real clinical benefit.
Could the Precision Peptide Genetic Test help me plan weight loss before IVF?
Yes. PlexusDx's Precision Peptide Genetic Test ($99 after your first month of semaglutide) analyzes 14 metabolic pathways and 49 peptides to identify your genetic predispositions for GLP-1 response. Understanding whether variants in GLP1R, GIPR, FTO, or MC4R affect your weight loss trajectory helps you and your doctors set realistic timelines before pausing therapy for IVF.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Diet on Ozempic: Can You Eat a Lot, and What Should You Prioritize?
Optimizing Protein Intake While on Ozempic: A Guide to Fueling Your Journey